Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

XPhyto to Announce PCR Test Kit Final Validation Results

It could be the Holy Grail of COVID-19 testing. Remarkably, a small Canadian life sciences company, XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) is becoming a front-runner in the race to bring this breakthrough technology to market – starting with Germany. This ref...
Marc Davis | November 26, 2020 |

Providing the perfect balance between media, data and technology

Welcome to the Market Herald Video Q&A podcast. I’m Brieanna McCutcheon. Today, we are joined by CEO Aziz Rahimtoola and CFO Sajid Premji from Sabio Holdings . I want to start off and say congratulations on the record quarters. TMH: Your...
Brieanna McCutcheon | September 8, 2022 |

Gold Set to Correct but Internals Remain Bullish

Last week we wrote that near-term risk in precious metals (Gold and GDX especially) was rising and a correction could begin soon. As Gold nearly reached major resistance at $1550/oz, the miners already began to correct. That negative divergence is an ominous signal for the...
Jordan Roy-Byrne, CMT | August 21, 2019 |

Feb 12th 2020, Crypto Chartbook – Consistently extracting profits

Consistently extracting profits In our chartbook publication from last week we published a chart with entry levels as a guide on when to enter the market. Briefly after publication, the first low risk price level was approached. Consequently we posted a screen...
Korbinian Koller | February 12, 2020 |

When Will it be Safe to Jump Back into the Gold and Silver Pool?

Once again the DSI (Daily Sentiment Indicator) made an accurate call on a major top in gold and silver. The DSI reached nosebleed territory for gold about four weeks ago suggesting the metals were nearing shoal waters. Silver and platinum got stupid a week ago and I su...
Streetwise Reports | September 13, 2019 |

Regeneron Reports Positive Phase 3 Dupixent Data; Gains EU Approval Recommendation

Regeneron Pharmaceuticals published positive results from two U.S. Phase 3 trials evaluating the safety and efficacy of Dupixent (dupilumab) in adults with recurring severe chronic rhinosinusitis with nasal polyps. The European Medicines Agency's Committee for Medicinal Produc...
Streetwise Reports | September 24, 2019 |

ResMed Shares Set 52-Week Intraday High Price After Posting Q1 Earnings

Shares of respiratory medical device maker and software applications company ResMed Inc. traded 15% higher at times today after the firm posted positive Q1/20 earnings results. Developer and manufacturer of medical devices and cloud-based software applications that di...
Streetwise Reports | October 26, 2019 |

Apellis Pharma Shares Rise 20% on Positive Top-line Data in Phase 3 PNH Trial

Shares of Apellis Pharmaceuticals opened 35% higher and established a new 52-week intraday high price today after the company announced positive top-line results from its Phase 3 head-to-head study of Pegcetacoplan (APL-2) versus Eculizumab in patients with Paroxysmal Nocturna...
Streetwise Reports | January 8, 2020 |

Grande Portage Resources Strikes Gold

Bob Moriarty of 321gold profiles an exploration junior with a high-grade project in the Juneau gold belt. There are a ton of tiny juniors out there who are taking advantage of a more favorable financing market to cash up and get cranking. One, with a tiny ma...
Streetwise Reports | February 18, 2020 |

MediciNova Shares Rise 40% on Plans to Initiate COVID-19 ARDS Clinical Trial

Shares of MediciNova traded higher after the company reported that it plans to initiate a clinical study of MN-166 (ibudilast) for COVID-19 acute respiratory distress syndrome. Biopharmaceutical company MediciNova, Inc. yesterday announced that "it will ...
Streetwise Reports | April 13, 2020 |
1 2 3